[Tyrosine kinase inhibitor STI571--a breakthrough in leukemia treatment?]

Postepy Biochem. 2003;49(3):157-67.

[Article in Polish]

Authors

Agnieszka Czechowska¹, Janusz Błasiak

Affiliation

¹ Katedra Genetyki Molekularnej Uniwersytetu Łódzkiego, ul. Banacha 12/16, 90-237 Łódź.

PMID: 15083608

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / chemistry
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Benzamides
Enzyme Inhibitors / chemistry
Enzyme Inhibitors / pharmacology
Enzyme Inhibitors / therapeutic use*
Humans
Imatinib Mesylate
Leukemia / drug therapy*
Piperazines / chemistry
Piperazines / pharmacology
Piperazines / therapeutic use*
Protein-Tyrosine Kinases / antagonists & inhibitors*
Pyrimidines / chemistry
Pyrimidines / pharmacology
Pyrimidines / therapeutic use*

Substances

Antineoplastic Agents
Benzamides
Enzyme Inhibitors
Piperazines
Pyrimidines
Imatinib Mesylate
Protein-Tyrosine Kinases